Boston Scientific Corporation disclosed a material cybersecurity incident that began on August 25, 2026, causing global operational disruptions including network outages that impaired manufacturing capabilities and the processing of customer orders. Although unauthorized access has not been identified as ongoing and major distribution centers have resumed shipping at normal levels, the company determined the incident will likely have a material impact on its third quarter and full-year 2026 results of operations. Consequently, Boston Scientific expects to miss its previously provided net sales growth and adjusted EPS guidance ranges for these periods. The company anticipates recovering some impacted revenue as it reduces backlogs but stated that full impacts remain unknown. Boston Scientific operates in the medical device industry, developing and manufacturing products for interventional and specialty medical procedures.
